Atlas Trials

To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis

Clinical trial NCT03412682 · COMPLETED

Trial details

NCT number
NCT03412682
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colitis, Ulcerative
Start date
2018-03-02
Primary completion
2020-05-11
Enrollment
274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.